The role of the gut in reverse cholesterol transport - Focus on the enterocyte

Progress in Lipid Research

Volumn 52, Issue 3, 2013, Pages 317-328

  Lee Rueckert, Miriam ^a   Blanco Vaca, Francisco ^b,c   Kovanen, Petri T ^a   Escola Gil, Joan Carles ^b  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Atherosclerosis; Cholesterol absorption; Enterocyte; Intestinal cholesterol transporters; Macrophage; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G5; ABC TRANSPORTER G8; CELL PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HETERODIMER; HIGH DENSITY LIPOPROTEIN; NIEMANN PICK C1 LIKE 1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ABCG5 GENE; ABCG8 GENE; ATHEROSCLEROSIS; BIOGENESIS; CHOLESTEROL TRANSPORT; DIABETES MELLITUS; DIET; FOAM CELL; HUMAN; INTESTINE; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE FLORA; MACROPHAGE; MENTAL STRESS; NONHUMAN; NPC1L1 GENE; NUTRITIONAL STATUS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE CHOLESTEROL TRANSPORT; REVIEW;

ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL, HDL; ENTEROCYTES; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; TRANSCRIPTION FACTORS;

EID: 84877655587     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2013.04.003     Document Type: Review

References (129)

1. C.J. Fielding, and P.E. Fielding Molecular physiology of reverse cholesterol transport J Lipid Res 36 2 1995 211 228
2. J.A. Glomset The plasma lecithins: cholesterol acyltransferase reaction J Lipid Res 9 2 1968 155 167
3. R.S. Rosenson, H.B. Brewer Jr, W.S. Davidson, Z.A. Fayad, V. Fuster, and J. Goldstein Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport Circulation 125 15 2012 1905 1919
4. A.E. van der Velde, G. Brufau, and A.K. Groen Transintestinal cholesterol efflux Curr Opin Lipidol 21 3 2010 167 171
5. M. Kockx, W. Jessup, and L. Kritharides Getting to the 'guts' of the matter: intestinal control of lipid metabolism Curr Opin Lipidol 24 1 2013 105 106
6. M. Cuchel, and D.J. Rader Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113 21 2006 2548 2555
7. X. Wang, H.L. Collins, M. Ranalletta, I.V. Fuki, J.T. Billheimer, and G.H. Rothblat Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo J Clin Invest 117 8 2007 2216 2224
8. Y. Zhang, F.C. McGillicuddy, C.C. Hinkle, S. O'Neill, J.M. Glick, and G.H. Rothblat Adipocyte modulation of high-density lipoprotein cholesterol Circulation 121 11 2010 1347 1355
9. A.V. Khera, M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M.F. Burke, and K. Jafri Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2 2011 127 135
10. D.J. Rader, and A.R. Tall The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat Med 18 9 2012 1344 1346
11. M. Eriksson, L.A. Carlson, T.A. Miettinen, and B. Angelin Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans Circulation 100 6 1999 594 598
12. A.V. Khera, and D.J. Rader Future therapeutic directions in reverse cholesterol transport Curr Atheroscler Rep 12 1 2010 73 81
13. Y. Zhang, I. Zanotti, M.P. Reilly, J.M. Glick, G.H. Rothblat, and D.J. Rader Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo Circulation 108 6 2003 661 663
14. D.J. Rader, E.T. Alexander, G.L. Weibel, J. Billheimer, and G.H. Rothblat The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis J Lipid Res 50 Suppl. 2009 S189 S194
15. J.C. Escola-Gil, N. Rotllan, J. Julve, and F. Blanco-Vaca In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection Atherosclerosis 206 2 2009 321 327
16. M. Lee-Rueckert, R. Silvennoinen, N. Rotllan, I. Judstrom, F. Blanco-Vaca, and J. Metso Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse Arterioscler Thromb Vasc Biol 31 3 2011 520 527
17. W. Annema, and U.J. Tietge Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies Nutr Metab (Lond) 9 1 2012 25
18. G.L. Weibel, S. Hayes, A. Wilson, M.C. Phillips, J. Billheimer, and D.J. Rader Novel in vivo method for measuring cholesterol mass flux in peripheral macrophages Arterioscler Thromb Vasc Biol 31 12 2011 2865 2871
19. N.A. Abumrad, and N.O. Davidson Role of the gut in lipid homeostasis Physiol Rev 92 3 2012 1061 1085
20. Y.A. Kesaniemi, and T.A. Miettinen Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population Eur J Clin Invest 17 5 1987 391 395
21. E. Quintao, S.M. Grundy, and E.H. Ahrens Jr Effects of dietary cholesterol on the regulation of total body cholesterol in man J Lipid Res 12 2 1971 233 247
22. R.E. Ostlund Jr, M.S. Bosner, and W.F. Stenson Cholesterol absorption efficiency declines at moderate dietary doses in normal human subjects J Lipid Res 40 8 1999 1453 1458
23. E. Sehayek, J.G. Ono, S. Shefer, L.B. Nguyen, N. Wang, and A.K. Batta Biliary cholesterol excretion: A novel mechanism that regulates dietary cholesterol absorption Proc Natl Acad Sci U S A 95 17 1998 10194 10199
24. S.W. Altmann, H.R. Davis Jr, L.J. Zhu, X. Yao, L.M. Hoos, and G. Tetzloff Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption Science 303 5661 2004 1201 1204
25. M. Garcia-Calvo, J. Lisnock, H.G. Bull, B.E. Hawes, D.A. Burnett, and M.P. Braun The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1) Proc Natl Acad Sci U S A 102 23 2005 8132 8137
26. L. Jia, J.L. Betters, and L. Yu Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport Annu Rev Physiol 73 2011 239 259
27. L. Yu, S. Bharadwaj, J.M. Brown, Y. Ma, W. Du, and M.A. Davis Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake J Biol Chem 281 10 2006 6616 6624
28. J.H. Zhang, L. Ge, W. Qi, L. Zhang, H.H. Miao, and B.L. Li The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake J Biol Chem 286 28 2011 25088 25097
29. M. Skov, C.K. Tonnesen, G.H. Hansen, and E.M. Danielsen Dietary cholesterol induces trafficking of intestinal Niemann-Pick Type C1 Like 1 from the brush border to endosomes Am J Physiol Gastrointest Liver Physiol 300 1 2011 G33 G40
30. E. Levy, A.B. Ouadda, S. Spahis, A.T. Sane, C. Garofalo, and E. Grenier PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells Atherosclerosis 227 2 2013 297 306
31. R.E. Temel, A.K. Gebre, J.S. Parks, and L.L. Rudel Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol J Biol Chem 278 48 2003 47594 47601
32. D.V. Nguyen, V.A. Drover, M. Knopfel, P. Dhanasekaran, H. Hauser, and M.C. Phillips Influence of class B scavenger receptors on cholesterol flux across the brush border membrane and intestinal absorption J Lipid Res 50 11 2009 2235 2244
33. B.M. El, S. Gilibert, M. Moreau, F. Saint-Charles, M. Treguier, and F. Poti Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis J Biol Chem 286 19 2011 17227 17238
34. H. Gylling, and T.A. Miettinen Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption J Lipid Res 43 9 2002 1472 1476
35. J. Wang, C.M. Williams, and R.A. Hegele Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe Clin Genet 67 2 2005 175 177
36. L. Pisciotta, T. Fasano, A. Bellocchio, L. Bocchi, R. Sallo, and R. Fresa Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients Atherosclerosis 194 2 2007 e116 e122
37. J.C. Cohen, A. Pertsemlidis, S. Fahmi, S. Esmail, G.L. Vega, and S.M. Grundy Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels Proc Natl Acad Sci U S A 103 6 2006 1810 1815
38. L.J. Wang, J. Wang, N. Li, L. Ge, B.L. Li, and B.L. Song Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers J Biol Chem 286 9 2011 7397 7408
39. T. Maeda, A. Honda, T. Ishikawa, M. Kinoshita, Y. Mashimo, and Y. Takeoka A SNP of NPC1L1 affects cholesterol absorption in Japanese J Atheroscler Thromb 17 4 2010 356 360
40. W.A. Alrefai, F. Annaba, Z. Sarwar, A. Dwivedi, S. Saksena, and A. Singla Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2 Am J Physiol Gastrointest Liver Physiol 292 1 2007 G369 G376
41. C. Duval, V. Touche, A. Tailleux, J.C. Fruchart, C. Fievet, and V. Clavey Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine Biochem Biophys Res Commun 340 4 2006 1259 1263
42. G. Lo Sasso, S. Murzilli, L. Salvatore, I. D'Errico, M. Petruzzelli, and P. Conca Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis Cell Metab 12 2 2010 187 193
43. X. Hu, K.R. Steffensen, Z.Y. Jiang, P. Parini, J.A. Gustafsson, and M. Gafvels LXRbeta activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile J Intern Med 272 5 2012 452 464
44. M.A. Valasek, S.L. Clarke, and J.J. Repa Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse J Lipid Res 48 12 2007 2725 2735
45. S. Colin, E. Bourguignon, A.B. Boullay, J.J. Tousaint, S. Huet, and F. Caira Intestine-specific regulation of PPARalpha gene transcription by liver X receptors Endocrinology 149 10 2008 5128 5135
46. R. Silvennoinen, J.C. Escola-Gil, J. Julve, N. Rotllan, G. Llaverias, and J. Metso Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption Circ Res 111 11 2012 1459 1469
47. J.N. van der Veen, J.K. Kruit, R. Havinga, J.F. Baller, G. Chimini, and S. Lestavel Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1 J Lipid Res 46 3 2005 526 534
48. E. Sehayek, and S.L. Hazen Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages Arterioscler Thromb Vasc Biol 28 7 2008 1296 1297
49. F. Briand, S.U. Naik, I. Fuki, J.S. Millar, C. Macphee, and M. Walker Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol Clin Transl Sci 2 2 2009 127 133
50. S.U. Naik, X. Wang, J.S. Da Silva, M. Jaye, C.H. Macphee, and M.P. Reilly Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo Circulation 113 1 2006 90 97
51. L. Calpe-Berdiel, N. Rotllan, C. Fievet, R. Roig, F. Blanco-Vaca, and J.C. Escola-Gil Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8 J Lipid Res 49 9 2008 1904 1911
52. F. Briand, M. Treguier, A. Andre, D. Grillot, M. Issandou, and K. Ouguerram Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model J Lipid Res 51 4 2010 763 770
53. Y. Zhang, L. Yin, J. Anderson, H. Ma, F.J. Gonzalez, and T.M. Willson Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia J Biol Chem 285 5 2010 3035 3043
54. H.R. Davis Jr, D.S. Compton, L. Hoos, and G. Tetzloff Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice Arterioscler Thromb Vasc Biol 21 12 2001 2032 2038
55. H.R. Davis Jr, L.M. Hoos, G. Tetzloff, M. Maguire, L.J. Zhu, and M.P. Graziano Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice Arterioscler Thromb Vasc Biol 27 4 2007 841 849
56. A.M. Gotto Jr, and J.E. Moon Recent clinical studies of the effects of lipid-modifying therapies Am J Cardiol 110 1 Suppl. 2012 15A 26A
57. M.E. Greenberg, J.D. Smith, and E. Sehayek Moderately decreased cholesterol absorption rates are associated with a large atheroprotective effect Arterioscler Thromb Vasc Biol 29 11 2009 1745 1750
58. K. Lu, M.H. Lee, H. Yu, Y. Zhou, S.A. Sandell, and G. Salen Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8 J Lipid Res 43 4 2002 565 578
59. W. Tang, Y. Ma, L. Jia, Y.A. Ioannou, J.P. Davies, and L. Yu Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8 J Lipid Res 50 2 2009 293 300
60. K.E. Berge, H. Tian, G.A. Graf, L. Yu, N.V. Grishin, and J. Schultz Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290 5497 2000 1771 1775
61. R.M. Weggemans, P.L. Zock, E.S. Tai, J.M. Ordovas, H.O. Molhuizen, and M.B. Katan ATP binding cassette G5 C1950G polymorphism may affect blood cholesterol concentrations in humans Clin Genet 62 3 2002 226 229
62. H. Gylling, M. Hallikainen, J. Pihlajamaki, J. Agren, M. Laakso, and R.A. Rajaratnam Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity J Lipid Res 45 9 2004 1660 1665
63. J.A. Hubacek, K.E. Berge, J. Stefkova, J. Pitha, Z. Skodova, and V. Lanska Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels Physiol Res 53 4 2004 395 401
64. K. Miwa, A. Inazu, J. Kobayashi, T. Higashikata, A. Nohara, and M. Kawashiri ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects Clin Sci (Lond) 109 2 2005 183 188
65. A. Garcia-Rios, P. Perez-Martinez, F. Fuentes, P. Mata, J. Lopez-Miranda, and R. Alonso Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia Atherosclerosis 210 2 2010 486 492
66. Q. Li, R.X. Yin, X.L. Wei, T.T. Yan, L.H. Aung, and D.F. Wu ATP-binding cassette transporter G5 and G8 polymorphisms and several environmental factors with serum lipid levels PLoS ONE 7 5 2012 e37972
67. J. Chen, A. Batta, S. Zheng, W.R. Fitzgibbon, M.E. Ullian, and H. Yu The missense mutation in Abcg5 gene in spontaneously hypertensive rats (SHR) segregates with phytosterolemia but not hypertension BMC Genet 6 2005 40
68. H.H. Wang, S.B. Patel, M.C. Carey, and D.Q. Wang Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice Hepatology 45 4 2007 998 1006
69. L. Yu, J. Li-Hawkins, R.E. Hammer, K.E. Berge, J.D. Horton, and J.C. Cohen Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol J Clin Invest 110 5 2002 671 680
70. K.R. Wilund, L. Yu, F. Xu, H.H. Hobbs, and J.C. Cohen High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-/- mice J Lipid Res 45 8 2004 1429 1436
71. J.E. Wu, F. Basso, R.D. Shamburek, M.J. Amar, B. Vaisman, and G. Szakacs Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice J Biol Chem 279 22 2004 22913 22925
72. Z. Li, T.S. Park, Y. Li, X. Pan, J. Iqbal, and D. Lu Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol Biochim Biophys Acta 1791 4 2009 297 306
73. F.J. Field, K. Watt, and S.N. Mathur Origins of intestinal ABCA1-mediated HDL-cholesterol J Lipid Res 49 12 2008 2605 2619
74. J.J. Repa, K.E. Berge, C. Pomajzl, J.A. Richardson, H. Hobbs, and D.J. Mangelsdorf Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta J Biol Chem 277 21 2002 18793 18800
75. L. Yu, J. York, B.K. Von, D. Lutjohann, J.C. Cohen, and H.H. Hobbs Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8 J Biol Chem 278 18 2003 15565 15570
76. T. Yasuda, D. Grillot, J.T. Billheimer, F. Briand, P. Delerive, and S. Huet Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo Arterioscler Thromb Vasc Biol 30 4 2010 781 786
77. A.L. Wu, and H.G. Windmueller Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat J Biol Chem 254 15 1979 7316 7322
78. J.M. Timmins, J.Y. Lee, E. Boudyguina, K.D. Kluckman, L.R. Brunham, and A. Mulya Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I J Clin Invest 115 5 2005 1333 1342
79. L.R. Brunham, J.K. Kruit, J. Iqbal, C. Fievet, J.M. Timmins, and T.D. Pape Intestinal ABCA1 directly contributes to HDL biogenesis in vivo J Clin Invest 116 4 2006 1052 1062
80. L.R. Brunham, J.K. Kruit, T.D. Pape, J.S. Parks, F. Kuipers, and M.R. Hayden Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels Circ Res 99 7 2006 672 674
81. P.H. Green, A.R. Tall, and R.M. Glickman Rat intestine secretes discoid high density lipoprotein J Clin Invest 61 2 1978 528 534
82. S. Murthy, E. Born, S.N. Mathur, and F.J. Field LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells J Lipid Res 43 7 2002 1054 1064
83. M. Lee-Rueckert, and P.T. Kovanen Extracellular modification of HDL and the evolving concept on the in-vivo proteolytic inactivation of prebeta-HDL as cholesterol acceptors Curr Opin Lipidol 22 2011 394 402
84. B.M. Khabazian, A. Ghanbari-Niaki, A. Safarzadeh-Golpordesari, M. Ebrahimi, F. Rahbarizadeh, and H. Abednazari Endurance training enhances ABCA1 expression in rat small intestine Eur J Appl Physiol 107 3 2009 351 358
85. J. McNeish, R.J. Aiello, D. Guyot, T. Turi, C. Gabel, and C. Aldinger High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1 Proc Natl Acad Sci U S A 97 8 2000 4245 4250
86. W. Drobnik, B. Lindenthal, B. Lieser, M. Ritter, W.T. Christiansen, and G. Liebisch ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism Gastroenterology 120 5 2001 1203 1211
87. B.L. Knight, D.D. Patel, S.M. Humphreys, D. Wiggins, and G.F. Gibbons Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice J Lipid Res 44 11 2003 2049 2058
88. W. Tang, Y. Ma, L. Jia, Y.A. Ioannou, J.P. Davies, and L. Yu Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice Arterioscler Thromb Vasc Biol 28 3 2008 448 454
89. S. Colin, O. Briand, V. Touche, K. Wouters, M. Baron, and F. Pattou Activation of intestinal peroxisome proliferator-activated receptor-alpha increases high-density lipoprotein production Eur Heart J 2012 10.1093/euroheartj/ehj227
90. L. Calpe-Berdiel, N. Rotllan, X. Palomer, V. Ribas, F. Blanco-Vaca, and J.C. Escola-Gil Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice Biochim Biophys Acta 1738 1-3 2005 6 9
91. C.L. Vrins From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux World J Gastroenterol 16 47 2010 5953 5957
92. R.E. Temel, and J.M. Brown Biliary and nonbiliary contributions to reverse cholesterol transport Curr Opin Lipidol 23 2 2012 85 90
93. J.N. van der Veen, T.H. van Dijk, C.L. Vrins, H. van Meer, R. Havinga, and K. Bijsterveld Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol J Biol Chem 284 29 2009 19211 19219
94. J.M. Brown, T.A. Bell III, H.M. Alger, J.K. Sawyer, T.L. Smith, and K. Kelley Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss J Biol Chem 283 16 2008 10522 10534
95. A.E. van der Velde, C.L. Vrins, K. van den Oever, C. Kunne, R.P. Oude Elferink, and F. Kuipers Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice Gastroenterology 133 3 2007 967 975
96. A.E. van der Velde, C.L. Vrins, K. van den Oever, I. Seemann, R.P. Oude Elferink, and Eck M. Van Regulation of direct transintestinal cholesterol excretion in mice Am J Physiol Gastrointest Liver Physiol 295 1 2008 G203 G208
97. C.L. Vrins, R. Ottenhoff, K. van den Oever, D.R. de Waart, J.K. Kruyt, and Y. Zhao Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein J Lipid Res 53 10 2012 2017 2023
98. E.M. Danielsen, G.H. Hansen, K. Rasmussen, L.L. Niels-Christiansen, and F. Frenzel Apolipoprotein A-1 (apoA-1) deposition in, and release from, the enterocyte brush border: a possible role in transintestinal cholesterol efflux (TICE)? Biochim Biophys Acta 1818 3 2012 530 536
99. C.L. Vrins, A.E. van der Velde, K. van den Oever, J.H. Levels, S. Huet, and R.P. Oude Elferink Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux J Lipid Res 50 10 2009 2046 2054
100. A.E. van der Velde, C.L. Vrins, K. van den Oever, I. Seemann, R.P. Oude Elferink, and M. van Eck Regulation of direct transintestinal cholesterol excretion in mice Am J Physiol Gastrointest Liver Physiol 295 1 2008 G203 G208
101. J.C. Escola-Gil, G. Llaverias, J. Julve, M. Jauhiainen, J. Mendez-Gonzalez, and F. Blanco-Vaca The cholesterol content of Western diets plays a major role in the paradoxical increase in high-density lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway Arterioscler Thromb Vasc Biol 31 11 2011 2493 2499
102. R.E. Temel, J.K. Sawyer, L. Yu, C. Lord, C. Degirolamo, and A. McDaniel Biliary sterol secretion is not required for macrophage reverse cholesterol transport Cell Metab 12 1 2010 96 102
103. N. Nijstad, T. Gautier, F. Briand, D.J. Rader, and U.J. Tietge Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice Gastroenterology 140 3 2011 1043 1051
104. L.P. Duan, H.H. Wang, A. Ohashi, and D.Q. Wang Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice. gender and age effects Am J Physiol Gastrointest Liver Physiol 290 2 2006 G269 G276
105. J.S. Cohn, A. Kamili, E. Wat, R.W. Chung, and S. Tandy Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications Atheroscler Suppl 11 1 2010 45 48
106. L. Calpe-Berdiel, J.C. Escola-Gil, and F. Blanco-Vaca New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism Atherosclerosis 203 1 2009 18 31
107. M. Nissinen, H. Gylling, M. Vuoristo, and T.A. Miettinen Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion Am J Physiol Gastrointest Liver Physiol 282 6 2002 G1009 G1015
108. G. Brufau, F. Kuipers, Y. Lin, E.A. Trautwein, and A.K. Groen A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice PLoS ONE 6 6 2011 e21576
109. R. Brauner, C. Johannes, F. Ploessl, F. Bracher, and R.L. Lorenz Phytosterols reduce cholesterol absorption by inhibition of 27- hydroxycholesterol generation, liver X receptor alpha activation, and expression of the basolateral sterol exporter ATP-binding cassette A1 in Caco-2 enterocytes J Nutr 142 6 2012 981 989
110. L. Calpe-Berdiel, J.C. Escola-Gil, and F. Blanco-Vaca Phytosterol-mediated inhibition of intestinal cholesterol absorption is independent of ATP-binding cassette transporter A1 Br J Nutr 95 3 2006 618 622
111. T. Plosch, J.K. Kruit, V.W. Bloks, N.C. Huijkman, R. Havinga, and G.S. Duchateau Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter J Nutr 136 8 2006 2135 2140
112. L. Calpe-Berdiel, J.C. Escola-Gil, and F. Blanco-Vaca Are LXR-regulated genes a major molecular target of plant sterols/stanols? Atherosclerosis 195 1 2007 210 211
113. L. Calpe-Berdiel, J.C. Escola-Gil, V. Ribas, A. Navarro-Sastre, J. Garces-Garces, and F. Blanco-Vaca Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet Atherosclerosis 181 1 2005 75 85
114. G. Silbernagel, B. Genser, P. Nestel, and W. Marz Plant sterols and atherosclerosis Curr Opin Lipidol 24 1 2013 12 17
115. A.M. Lottenberg, R.P. Bombo, A. Ilha, V.S. Nunes, E.R. Nakandakare, and E.C. Quintao Do clinical and experimental investigations support an antiatherogenic role for dietary phytosterols/stanols? IUBMB Life 64 4 2012 296 306
116. G. Llaverias, J.C. Escola-Gil, E. Lerma, J. Julve, C. Pons, and A. Cabre Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer J Nutr Biochem 24 1 2012 39 48
117. A. Alvaro, R. Rosales, L. Masana, and J.C. Vallve Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids J Nutr Biochem 21 6 2010 518 525
118. S.N. Mathur, K.R. Watt, and F.J. Field Regulation of intestinal NPC1L1 expression by dietary fish oil and docosahexaenoic acid J Lipid Res 48 2 2007 395 404
119. T. Nishimoto, M.A. Pellizzon, M. Aihara, I.M. Stylianou, J.T. Billheimer, and G. Rothblat Fish oil promotes macrophage reverse cholesterol transport in mice Arterioscler Thromb Vasc Biol 29 10 2009 1502 1508
120. K.Y. Ma, N. Yang, R. Jiao, C. Peng, L. Guan, and Y. Huang Dietary calcium decreases plasma cholesterol by down-regulation of intestinal Niemann-Pick C1 like 1 and microsomal triacylglycerol transport protein and up-regulation of CYP7A1 and ABCG 5/8 in hamsters Mol Nutr Food Res 55 2 2011 247 258
121. S.I. Sayin, A. Wahlstrom, J. Felin, S. Jantti, H.U. Marschall, and K. Bamberg Gut microbiota regulates bile acid metabolism by reducing the levels of Tauro-beta-muricholic acid, a naturally occurring FXR antagonist Cell Metab 17 2 2013 225 235
122. Z. Wang, E. Klipfell, B.J. Bennett, R. Koeth, B.S. Levison, and B. Dugar Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 472 7341 2011 57 63
123. D. Wang, M. Xia, X. Yan, D. Li, L. Wang, and Y. Xu Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b Circ Res 111 8 2012 967 981
124. Z. Ravid, M. Bendayan, E. Delvin, A.T. Sane, M. Elchebly, and J. Lafond Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors Am J Physiol Gastrointest Liver Physiol 295 5 2008 G873 G885
125. S. Lally, C.Y. Tan, D. Owens, and G.H. Tomkin Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein Diabetologia 49 5 2006 1008 1016
126. H. Gylling, D.E. Laaksonen, M. Atalay, M. Hallikainen, L. Niskanen, and T.A. Miettinen Markers of absorption and synthesis of cholesterol in men with type 1 diabetes Diabetes Metab Res Rev 23 5 2007 372 377
127. F. Briand, Q. Thieblemont, E. Muzotte, and T. Sulpice High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters J Nutr 142 4 2012 704 709
128. J.F. de Boer, W. Annema, M. Schreurs, J.N. van der Veen, M. van der Giet, and N. Nijstad Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice J Lipid Res 53 3 2012 348 357
129. F. Briand, Q. Thieblemont, R. Burcelin, and T. Sulpice Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice Diabetes Obes Metab 14 7 2012 662 665